Skip to main content

Neuroprotective Therapy with Citicoline (Ceraxon) in Patients with Ischemic Stroke

The dynamics of neurological symptoms were assessed using the Scandinavia Stroke Scale and functional disease outcomes with the Barthel index and modified Rankin scale in 89 patients during the acute period of ischemic stroke of moderate severity, whose treatment included citicoline (Ceraxon) i.v. and p.o. The results were compared with those from a reference group (52 patients) selected in terms of clinical and demographic parameters, who received similar treatment without citicoline. By discharge from hospital (days 21–24 of illness), there was significantly (p < 0.05) greater recovery in the study group. The efficacy of citicoline was significantly (p < 0.05) greater in patients aged less than 70 years and when citicoline was given in the first hours of illness.

This is a preview of subscription content, access via your institution.

References

  1. E. I. Gusev, V. I. Skvortsova, and L. V. Stakhovskaya, “The problem of stroke in the Russian Federation: a time for positive actions,” Zh. Nevrol. Psikhiat., 107, No. 6, 4–10 (2007).

    CAS  Google Scholar 

  2. P. A. Lapchak, “Emerging therapies: pleiotropic multi-target drugs to treat stroke victims,” Transl. Stroke Res., 2, 129–135 (2011).

    PubMed  Article  Google Scholar 

  3. M. D. Ginsberg, “Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection: The 2002 Thomas Willis Lecture,” Stroke, 34, 214–223 (2003).

    PubMed  Article  Google Scholar 

  4. E. I. Gusev, A. N. Boiko, V. L. Baratashvili, et al., “Results obtained using citicoline (Ceraxon) in patients with acute cerebral stroke,” Med. Krit. Sostoyanii, 2, 42–47 (2010).

    Google Scholar 

  5. A. Rogalewski, A. Schneider, B. E. Ringelstein, and W. R. Schabitz, “Toward a multimodal neuroprotective treatment of stroke,” Stroke, 37, 1129–1136 (2006).

    PubMed  Article  Google Scholar 

  6. A. A. Mangoni and S. H. Jackson, “Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications,” Brit. J. Clin. Pharmacol., 57, No. 1, 6–14 (2004).

    Article  CAS  Google Scholar 

  7. G. Trifiró and E. Spina, “Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems,” Curr. Drug. Metab., 12, No. 4, 542–549 (2011).

    Google Scholar 

  8. X. Bao, P. J. Mills, B. K. Rana, et al., “Interactive effects of common β2-adrenoceptor haplotypes and age on susceptibility to hypertension and receptor function,” Hypertension, 46, 301–307 (2005).

    PubMed  Article  CAS  Google Scholar 

  9. M. Meller, S. Jakobsen, and A. Gjedde, “Parametric and regional maps of free serotonin 5-HT1A receptor sites in human brain as function of age in healthy humans,” Neuropsychopharmacology, 32, 1707–1714 (2007).

    Article  Google Scholar 

  10. R. M. Adibhatla, J. F. Hatcher, E. C. Larsen, et al., “CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP:phosphocholine cytidyltransferase after stroke,” J. Biol. Chem., 281, No. 10, 6718–6725 (2005).

    PubMed  Article  Google Scholar 

  11. A. Farooqui, L. Horrocks, and T. Farooqui, “Glycerophospholipids in brain: their metabolism, incorporation to membranes, functions, and involvement in neurological disorders,” Chem. Phys. Lipids, 106, 1–29 (2000).

    PubMed  Article  CAS  Google Scholar 

  12. Z. Li and D. E. Vance, “Phosphatidylcholine and choline homeostasis,” J. Lipid Res., 49, 1187–1194 (2008).

    PubMed  Article  CAS  Google Scholar 

  13. O. Hurtado, M. A. Moro, A. Cárdenas, et al., “Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport,” Neurobiol. Dis., 18, 336–345 (2005).

    PubMed  Article  CAS  Google Scholar 

  14. M. Martinet, P. Fonlupt, and H. Pacheco, “Effects of cytidine 5'-diphosphocholine on norepinephrine, dopamine and serotonin synthesis in various regions of the rat brain,” Arch. Int. Pharmacodyn. Ther., 239, 52–61 (1979).

    PubMed  CAS  Google Scholar 

  15. M. Alonso de Laciñana, M. Gutiérrez, J. M. Rada, et al., “Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke,” J. Neurol. Sci., 247, 121–129 (2006).

    Article  Google Scholar 

  16. O. Hurtado, A. Cardenas, J. M. Pradillo, et al., “A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke,” Neurobiol. Dis., 26, 105–111 (2007).

    PubMed  Article  CAS  Google Scholar 

  17. J. Alvarez-Sabín and G. C. Román, “Citicoline in vascular cognitive impairment and vascular dementia after stroke,” Stroke, 42, Suppl., 40–43 (2011).

    Article  Google Scholar 

  18. R. A. Cohen, J. N. Browndyke, D. J. Moser, et al., “Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes,” Cerebrovasc. Dis., 16, 199–204 (2003).

    PubMed  Article  CAS  Google Scholar 

  19. M. M. Odinak and I. A. Voznyuk, “The role of exogenous choline in protection and recovery of brain matter in stroke. Quality of life,” Meditsina, 21, No. 4, 1–7 (2007).

    Google Scholar 

  20. W. M. Clark, S. J. Warach, L. C. Pettigrew, et al., “A randomized dose–response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group,” Neurology, 49, 671–678 (1997).

    PubMed  Article  CAS  Google Scholar 

  21. A. Davalos, J. Castillo, J. Alvarez-Sabin, et al., “Oral citicoline in acute ischemic stroke: An individual patient data pooling analysis of clinical trials,” Stroke, 33, No. 12, 2850–2857 (2002).

    PubMed  Article  CAS  Google Scholar 

  22. S. Warach, L. C. Pettigrew, J. F. Dashe, et al., “Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging,” Citicoline 010 investigators,” Ann. Neurol., 48, No. 5, 713–722 (2000).

    PubMed  Article  CAS  Google Scholar 

  23. M. F. Kuo, J. Grosch, E. Fregni, et al., “Focusing effect of acetylcholine on neuroplasticity in the human motor cortex,” J. Neurosci., 27, No. 52, 14442–14447 (2007).

    PubMed  Article  CAS  Google Scholar 

  24. F. Meintzschel and U. Ziemann, “Modification of practice-dependent plasticity in human motor cortex by neuromodulators,” Cerebral Cortex, 16, 1106–1115 (2006).

    PubMed  Article  Google Scholar 

  25. M. M. Silveri, J. Dikan, A. J. Ross, et al., “Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy,” NMR Biomed., 21, 1066–1075 (2008).

    PubMed  Article  CAS  Google Scholar 

  26. V. Rema, K. K. Bali, R. Ramachandra, et al., “Cytidine-5-diphosphocholine supplement early in life induces stable increase in dendritic complexity of neurons in the somatosensory cortex of adult rats,” Neurosci., 155, No. 2, 556–564 (2008).

    Article  CAS  Google Scholar 

  27. V. Bramanti, D. Bronzi, D. Tomassoni, et al., “Effect of choline-containing phospholipids on transglutaminase activity in primary astroglial cell cultures,” Clin. Exp. Hypertens., 30, No. 8, 798–807 (2008).

    PubMed  Article  CAS  Google Scholar 

  28. I. D. Grachev and A. V. Apkarian, “Aging alters regional multichemical profile of the human brain: an in vivo 1H-MRS study of young versus middle-aged subjects,” J. Neurochem., 76, 582–593 (2001).

    PubMed  Article  CAS  Google Scholar 

  29. K. Haga, Y. Khor, A. Farrall, and J. M. Wardlaw, “A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging,” Neurobiol. Aging, 30, 353–363 (2009).

    PubMed  Article  CAS  Google Scholar 

  30. M. Castellanos, T. Sobrino, and J. Castillo, “Evolving paradigms for neuroprotection: molecular identification of ischemic penumbra,” Cerebrovasc. Dis., 21, No. 2, 71–79 (2006).

    PubMed  Article  Google Scholar 

  31. T. J. Quinn, P. Langhorne, and D. J. Stott, “Barthel index for stroke trials: development, properties, and application,” Stroke, 42, 1146–1151 (2011).

    PubMed  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Yu. Martynov.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 112, No. 3, Iss. II, Stroke, pp. 21–26, February, 2012.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Martynov, M.Y., Boiko, A.N., Kamchatnov, P.R. et al. Neuroprotective Therapy with Citicoline (Ceraxon) in Patients with Ischemic Stroke. Neurosci Behav Physi 43, 706–711 (2013). https://doi.org/10.1007/s11055-013-9797-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-013-9797-x

Keywords

  • ischemic stroke
  • cytoprotective therapy
  • citicoline